Mergers and Acquisitions

NewsMay 20, 2021

Nemphos Braue Adds Corporate Associate and Paralegal

With a growing roster of clients in the mid-Atlantic and beyond, the firm is expanding and adding two team members.

WebinarsApr 10, 2021

M&A: The “COVID Hangover” and Fielding the Best Team

George Nemphos shares details on what he sees as the “COVID hangover” and tips on fielding the best team on the field when going into a deal.

WebinarsMar 23, 2021

M&A Success: Find Your Happy Ever After

Join sbLiftOff CEO Sharon Heaton and Nemphos Braue Founding Partner George Nemphos as they share M&A success insights including how to bring the right buyer to the right seller for a happy outcome.

NewsJan 26, 2021

Nemphos Braue Represents Amalgam Rx in Acquisition of Avhana Health

Amalgam Rx Inc., a growing digital health company represented by Baltimore-based boutique law firm Nemphos Braue LLC, has completed its acquisition of Avhana Health Inc., creator of a SaaS-based tool integrated with the leading electronic health records (EHR) companies.

NewsDec 7, 2020

Nemphos Braue Represents ICSG Group in Acquisition and Finance of Incorp Holdings LLC

BALTIMORE — Nemphos Braue LLC, a boutique law firm with extensive corporate law expertise, announces the successful closing of a multi-million, multi-investor acquisition of Incorp Holdings, LLC.

WebinarsOct 27, 2020

Risk Allocation

Risk allocation is a tenet of all mergers and acquisitions, not just during a pandemic, and certain “phantoms” may be lurking in the details.

WebinarsOct 22, 2020

Valuations in the Time of Covid

Estimating a business owner or organization’s value is critical for growth and for exit or transition strategies.

WebinarsOct 15, 2020

George Nemphos Explains Economic Herd Immunity

At the recent virtual event The Road Map: Valuing and Positioning Your Business for the Next Destination, Co-Founder George Nemphos spoke on the importance of what he calls “economic herd immunity” – a cooperative business model to help all businesses during the pandemic.